SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 199 filers reported holding SEATTLE GENETICS INC in Q2 2013. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,549,000 | -64.1% | 15,000 | -75.9% | 0.03% | -46.4% |
Q4 2019 | $7,102,000 | +649.9% | 62,154 | +460.6% | 0.06% | +600.0% |
Q3 2019 | $947,000 | -85.0% | 11,088 | -87.8% | 0.01% | -82.6% |
Q2 2019 | $6,315,000 | -21.0% | 91,235 | -16.4% | 0.05% | -30.3% |
Q1 2019 | $7,992,000 | +80.9% | 109,124 | +39.9% | 0.07% | +83.3% |
Q4 2018 | $4,419,000 | +159.6% | 77,988 | +204.3% | 0.04% | +260.0% |
Q2 2018 | $1,702,000 | +742.6% | 25,631 | +699.0% | 0.01% | +400.0% |
Q1 2017 | $202,000 | -56.2% | 3,208 | -62.4% | 0.00% | 0.0% |
Q3 2016 | $461,000 | -93.4% | 8,537 | -95.7% | 0.00% | -95.0% |
Q1 2016 | $7,018,000 | +110.4% | 200,000 | +169.1% | 0.04% | +100.0% |
Q4 2015 | $3,336,000 | +178.7% | 74,333 | +139.3% | 0.02% | +185.7% |
Q3 2015 | $1,197,000 | -52.4% | 31,063 | -40.2% | 0.01% | -46.2% |
Q2 2015 | $2,515,000 | -75.7% | 51,968 | -81.3% | 0.01% | -81.7% |
Q3 2014 | $10,348,000 | +399.7% | 278,300 | +322.7% | 0.07% | +222.7% |
Q2 2013 | $2,071,000 | – | 65,838 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |